Reagents/consumables/controls for cobas 5800 testing system

Ended Purchase Order Awarded Last action

Contract number
W81K0224P0059
Awardee
Awarding agency
Obligated
$297,477

Award facts

Contract value 40% obligated
  • $446,215.98 Current, with exercised options
  • $743,693.30 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00007 $0
Other Administrative Action P00006 · Molecular analyzer, reagents, and consumables $0
Other Administrative Action P00005 $0
Funding Only Action P00004 $148,739
Exercise an Option P00003 · The purpose of this modification is to exercise option period one (1) of the contract. The government hereby exercises option period one under the contract… $0
Funding Only Action P00002 · Cobas 58/68/8800 HPV 480T IVD kit - obligate FY25 funding $148,739
Supplemental Agreement for work within scope P00001 · Cobas 58/68/8800 HPV 480T IVD kit - revise clin structure & add 2 items $0
Original award $0

About this award

The Defense Health Agency awarded a purchase order to Roche Diagnostics Corporation on October 1, 2024, for reagents, consumables, and controls for COBAS 5800 testing systems, with a ceiling value of $743,693.30 and ultimate completion date of September 30, 2028. Work is performed at Castleton, Indiana. The order is firm fixed price for molecular analyzer reagents and consumables supporting automated laboratory diagnostic testing. The originating procurement was a sources-sought notice posted by Madigan Army Medical Center on March 18, 2024, for HPV molecular diagnostics analyzer and reagents rental with a base 12-month period and four one-year options, conducted under FAR Part 13.5 simplified procedures for commercial products. NAICS code 325413 applies.

Quick answers

Who was awarded contract W81K0224P0059?

W81K0224P0059 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on October 1, 2024.

How much is contract W81K0224P0059 worth?

The government has obligated $297,477 on W81K0224P0059. Its current value, with exercised options, is $446,216. Its potential value, with all options, is $743,693.

Was contract W81K0224P0059 competed?

The extent of competition for W81K0224P0059 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award